Zentalis Pharmaceuticals Llc (ZNTL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
255,614,000
EV to revenue ratio (TTM)
7.77
EV to ebitda
-2.313
Financial Performance
Revenue (TTM)
26,865,000
Gross profit (TTM)
26,865,000
EBITDA
-149,768,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-33.20%
Return on equity (TTM)
-66.70%
Per Share Metrics
Revenue per share (TTM)
0.37
EPS
-1.96
Diluted EPS (TTM)
-1.96
Book value
2
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
7.13
Price to book ratio (TTM)
1.891
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
4
Hold
5
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.862